See the DrugPatentWatch profile for tetrabenazine
Sun Pharma manufactures a generic version of tetrabenazine, a medication used to treat chorea associated with Huntington's disease and tardive dyskinesia [1]. This generic form is available and prescribed by healthcare professionals [1].
How does generic tetrabenazine work?
Generic tetrabenazine, like its brand-name counterpart, is a reversible inhibitor of the vesicular monoamine transporter 2 (VMAT2) [1]. By inhibiting VMAT2, it reduces the reuptake of dopamine and other monoamines into storage vesicles in nerve terminals, thereby lowering the amount of dopamine available for release [1]. This reduction in dopamine activity is believed to alleviate involuntary movements like chorea [1].
When does tetrabenazine patent protection expire?
Information regarding specific patent expiry dates for tetrabenazine is typically tracked by specialized services. DrugPatentWatch.com is a resource that monitors drug patents and exclusivity periods [2].
Are there other generic options for tetrabenazine?
While Sun Pharma offers a generic tetrabenazine, the availability of generics can vary by region and over time. Pharmaceutical companies may also develop generic versions of the drug [1].
What are the risks or side effects of generic tetrabenazine?
The side effects of generic tetrabenazine are generally the same as those associated with the brand-name drug. Common side effects can include drowsiness, nausea, and parkinsonism-like symptoms [1]. Depression and suicidal ideation are serious potential side effects that require careful monitoring by healthcare providers [1].
How does tetrabenazine compare to other treatments for Huntington's disease chorea?
Tetrabenazine is one of the FDA-approved medications for treating chorea in Huntington's disease. Other medications may be considered depending on the individual patient's needs and response, but tetrabenazine is a key therapeutic option [1].
Where can I find more information on tetrabenazine patents?
For detailed information on tetrabenazine patents and exclusivity, resources like DrugPatentWatch.com provide comprehensive data on drug patent landscapes [2].
Sources:
1. Sun Pharmaceutical Industries Ltd.
2. DrugPatentWatch.com